These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26622756)

  • 21. [HISTOLOGICAL ANALYSIS OF BONE DESTRUCTION IN SPINAL TUBERCULOSIS].
    Izawa K
    Kekkaku; 2015 Mar; 90(3):415-20. PubMed ID: 26477111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
    Zhu Y; Zhou J; Ji Y; Yu B
    Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Receptor activator for nuclear factor κ B expression predicts poor prognosis in breast cancer patients with bone metastasis but not in patients with visceral metastasis.
    Zhang L; Teng Y; Zhang Y; Liu J; Xu L; Qu J; Hou K; Yang X; Liu Y; Qu X
    J Clin Pathol; 2012 Jan; 65(1):36-40. PubMed ID: 22049226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
    Xu J; Xie L; Guo W
    Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.
    Sakai E; Aoki Y; Yoshimatsu M; Nishishita K; Iwatake M; Fukuma Y; Okamoto K; Tanaka T; Tsukuba T
    Phytomedicine; 2016 Jul; 23(8):828-37. PubMed ID: 27288918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma.
    Roux S; Meignin V; Quillard J; Meduri G; Guiochon-Mantel A; Fermand JP; Milgrom E; Mariette X
    Br J Haematol; 2002 Apr; 117(1):86-92. PubMed ID: 11918537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line.
    Mackie PS; Fisher JL; Zhou H; Choong PF
    Br J Cancer; 2001 Apr; 84(7):951-8. PubMed ID: 11286476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VEGF expression as a prognostic marker in osteosarcoma.
    Bajpai J; Sharma M; Sreenivas V; Kumar R; Gamnagatti S; Khan SA; Rastogi S; Malhotra A; Bakhshi S
    Pediatr Blood Cancer; 2009 Dec; 53(6):1035-9. PubMed ID: 19621435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course.
    Clar KL; Weber LM; Schmied BJ; Heitmann JS; Marconato M; Tandler C; Schneider P; Salih HR
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local host response in osteosarcoma after chemotherapy referred to radiographs, CT, tumour necrosis and patient survival.
    Lindner NJ; Scarborough MT; Spanier SS; Enneking WF
    J Cancer Res Clin Oncol; 1998; 124(10):575-80. PubMed ID: 9829862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy.
    Loibl S; Müller BM; von Minckwitz G; Schwabe M; Roller M; Darb-Esfahani S; Ataseven B; du Bois A; Fissler-Eckhoff A; Gerber B; Kulmer U; Alles JU; Mehta K; Denkert C
    Breast Cancer Res Treat; 2011 Nov; 130(2):477-87. PubMed ID: 21837479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
    Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
    Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic and therapeutic factors which influence the oncological outcome of parosteal osteosarcoma.
    Laitinen M; Parry M; Albergo JI; Jeys L; Abudu A; Carter S; Sumathi V; Grimer R
    Bone Joint J; 2015 Dec; 97-B(12):1698-703. PubMed ID: 26637687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Osteoclast differentiation regulated by receptor activator of nuclear factor kappaB probably through a novel signaling pathway].
    Xu DR; Chen HZ; Wang HH; Li J; Luo SK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):607-11. PubMed ID: 19549373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
    J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.
    Uchibori M; Nishida Y; Nagasaka T; Yamada Y; Nakanishi K; Ishiguro N
    Int J Oncol; 2006 Jan; 28(1):33-42. PubMed ID: 16327977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases.
    Ward WG; Mikaelian K; Dorey F; Mirra JM; Sassoon A; Holmes EC; Eilber FR; Eckardt JJ
    J Clin Oncol; 1994 Sep; 12(9):1849-58. PubMed ID: 8083708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A preliminary investigation of Beta-hCG expression in patients with osteosarcoma.
    Masrouha KZ; Khattab R; Tawil A; Abdallah A; Saghieh S; Haidar R; Abboud M; Khoury NJ
    J Bone Joint Surg Br; 2012 Mar; 94(3):419-24. PubMed ID: 22371553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.